Individual-Based Simulation Models of HIV Transmission: Reporting Quality and Recommendations

PLoS ONE

Volumn 8, Issue 9, 2013, Pages

  Abuelezam, Nadia N ^a   Rough, Kathryn ^a   Seage III, George R ^a  

^a HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANALYTICAL PARAMETERS; ARTICLE; CALIBRATION; HEALTH CARE POLICY; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION PREVENTION; INTERNAL VALIDITY; MATHEMATICAL MODEL; MEDICAL LITERATURE; PRACTICE GUIDELINE; PUBLICATION; QUALITY CONTROL; SIMULATION; VIRUS TRANSMISSION;

COMPUTER SIMULATION; DISEASE NOTIFICATION; HIV INFECTIONS; HUMANS; INDIVIDUALIZED MEDICINE; MODELS, BIOLOGICAL;

EID: 84884802482     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0075624     Document Type: Article

References (52)

1. Stover J, (2000) Influence of mathematical modeling of HIV and AIDS on policies and programs in the developing world. Sex Transm Dis 27: 572-578. doi:10.1097/00007435-200011000-00005. PubMed: 11099072.
2. Gilbert N, (2007) Agent-based models. Sage Publications, Incorporated.
3. Law AM, Kelton WD, (1991) Simulation modeling and analysis. New York: McGraw-Hill.
4. Marshall B, Paczkowski M, Tempalski B, Pouget E, Friedman S, et al. (2012) Combination interventions for the prevention of HIV among injection drug users: a complex systems dynamics model. J Int AIDS Soc 15: 108.
5. Delva W, Wilson DP, Abu-Raddad L, Gorgens M, Wilson D, et al. (2012) HIV Treatment as Prevention: Principles of Good HIV Epidemiology Modelling for Public Health Decision-Making in All Modes of Prevention and Evaluation. PLOS Med 9: e1001239. PubMed: 22802729.
6. Garnett GP, Cousens S, Hallett TB, Steketee R, Walker N, (2011) Mathematical models in the evaluation of health programmes. Lancet 378: 515-525. doi:10.1016/S0140-6736(10)61505-X. PubMed: 21481448.
7. Richiardi M, Leombruni R, Saam N, Sonnessa M, (2006) A common protocol for agent-based social simulation. J Artif Soc Soc 9.
8. Fone D, Hollinghurst S, Temple M, Round A, Lester N, et al. (2003) Systematic review of the use and value of computer simulation modelling in population health and health care delivery. J Public Health (Oxf) 25: 325-335. doi:10.1093/pubmed/fdg075. PubMed: 14747592.
9. Rutter CM, Zaslavsky AM, Feuer EJ, (2011) Dynamic Microsimulation Models for Health Outcomes A Review. Med Decis Mak 31: 10-18. doi:10.1177/0272989X10369005.
10. Philips Z, Bojke L, Sculpher M, Claxton K, Golder S, (2006) Good practice guidelines for decision-analytic modelling in health technology assessment: a review and consolidation of quality assessment. Pharmacoeconomics 24: 355-371. doi:10.2165/00019053-200624040-00006. PubMed: 16605282.
11. Grimm V, Berger U, Bastiansen F, Eliassen S, Ginot V, et al. (2006) A standard protocol for describing individual-based and agent-based models. Ecol Modell 198: 115-126. doi:10.1016/j.ecolmodel.2006.04.023.
12. Moher D, Hopewell S, Schulz KF, Montori V, Gøtzsche PC, et al. (2010) CONSORT 2010 explanation and elaboration: updated guidelines for reporting parallel group randomised trials. BMJ 340: c869. doi:10.1136/bmj.c869. PubMed: 20332511.
13. Van Imhoff E, Post W, (1998) Microsimulation methods for population projection. Population: An English Selection: pp. 97-138. PubMed: 12157954.
14. Karplus WJ, (1977) The spectrum of mathematical modeling and systems simulation. Math Comput Simulat 19: 3-10. doi:10.1016/0378-4754(77)90034-9.
15. Marshall BD, Paczkowski MM, Seemann L, Tempalski B, Pouget ER, et al. (2012) A complex systems approach to evaluate HIV prevention in metropolitan areas: preliminary implications for combination intervention strategies. PLOS ONE 7: e44833. doi:10.1371/journal.pone.0044833. PubMed: 23028637.
16. Halpin B, (1999) Simulation in sociology. Am Behav Sci 42: 1488-1508. doi:10.1177/0002764299042010003.
17. Adams AL, Barth-Jones DC, Chick SE, Koopman JS, (1998) Simulations to evaluate HIV vaccine trial designs. Simul 71: 228-241. doi:10.1177/003754979807100403.
18. Amirfar S, Hollenberg JP, Abdool Karim SS, (2006) Modeling the impact of a partially effective HIV vaccine on HIV infection and death among women and infants in South Africa. J Acquir Immune Defic Syndr 43: 219-225. doi:10.1097/01.qai.0000230526.79341.83. PubMed: 16951648.
19. Gray RH, Li XB, Wawer MJ, Gange SJ, Serwadda D, et al. (2003) Stochastic simulation of the impact of antiretroviral therapy and HIV vaccines on HIV transmission; Rakai, Uganda. AIDS 17: 1941-1951. doi:10.1097/00002030-200309050-00013. PubMed: 12960827.
20. Gray RT, Ghaus MH, Hoare A, Wilson DP, (2011) Expected epidemiological impact of the introduction of a partially effective HIV vaccine among men who have sex with men in Australia. Vaccine 29: 6125-6129. doi:10.1016/j.vaccine.2011.06.061. PubMed: 21703320.
21. Hontelez JA, Nagelkerke N, Bärnighausen T, Bakker R, Tanser F, et al. (2011) The potential impact of RV144-like vaccines in rural South Africa: a study using the STDSIM microsimulation model. Vaccine 29: 6100-6106. doi:10.1016/j.vaccine.2011.06.059. PubMed: 21703321.
22. Vieira IT, Cheng RCH, Harper PR, de Senna V, (2010) Small world network models of the dynamics of HIV infection. Ann Oper Res 178: 173-200. doi:10.1007/s10479-009-0571-y.
23. Gray RH, Li XB, Kigozi G, Serwadda D, Nalugoda F, et al. (2007) The impact of male circumcision on HIV incidence and cost per infection prevented: a stochastic simulation model from Rakai, Uganda. AIDS 21: 845-850. doi:10.1097/QAD.0b013e3280187544. PubMed: 17415039.
24. White RG, Glynn JR, Orroth KK, Freeman EE, Bakker R, et al. (2008) Male circumcision for HIV prevention in sub-Saharan Africa: who, what and when? AIDS 22: 1841-1850. doi:10.1097/QAD.0b013e32830e0137. PubMed: 18753931.
25. Bernstein RS, Sokal DC, Seitz ST, Auvert B, Stover J, et al. (1998) Simulating the control of a heterosexual HIV epidemic in a severely affected east African city. Interfaces 28: 101-126. doi:10.1287/inte.28.3.101.
26. Beyrer C, Baral SD, van Griensven F, Goodreau SM, Chariyalertsak S, et al. (2012) Global epidemiology of HIV infection in men who have sex with men. Lancet 380: 367-377. doi:10.1016/S0140-6736(12)60821-6. PubMed: 22819660.
27. Bracher M, Santow G, Watkins SC, (2004) Assessing the potential of condom use to prevent the spread of HIV: A microsimulation study. Stud Fam Plann 35: 48-64. doi:10.1111/j.1728-4465.2004.00005.x. PubMed: 15067788.
28. Hallett TB, Smit C, Garnett GP, de Wolf F, (2011) Estimating the risk of HIV transmission from homosexual men receiving treatment to their HIV-uninfected partners. Sex Transm Infect 87: 17-21. doi:10.1136/sextrans-2011-050102.58. PubMed: 20643658.
29. Robinson NJ, Mulder DW, Auvert B, Hayes RJ, (1995) Modelling the impact of alternative HIV intervention strategies in rural Uganda. AIDS 9: 1263-1270. doi:10.1097/00002030-199511000-00008. PubMed: 8561980.
30. Van der Ploeg CPB, Van Vliet C, De Vlas SJ, Ndinya-Achola JO, Fransen L, et al. (1998) STDSIM: A microsimulation model for decision support in STD control. Interfaces 28: 84-100. doi:10.1287/inte.28.3.84.
31. van Vliet C, Meester EI, Korenromp EL, Singer B, Bakker R, et al. (2001) Focusing strategies of condom use against HIV in different behavioural settings: an evaluation based on a simulation model. Bull World Health Organ 79: 442-454. PubMed: 11417040.
32. Vissers DC, SJ DEV, Bakker R, Urassa M, Voeten HA,et al (2011) The impact of mobility on HIV control: a modelling study. Epidemiol Infect 139: 1845-1853. doi:10.1017/S0950268811000069. PubMed: 21299914.
33. Enns EA, Brandeau ML, (2011) Inferring model parameters in network-based disease simulation. Health Care Manag Sci 14: 174-188. doi:10.1007/s10729-011-9150-2. PubMed: 21373984.
34. McCreesh N, O'Brien K, Nsubuga R, Shafer A L, Bakker R, et al. (2011) Exploring the potential impact on hiv incidence of a reduction in concurrency in rural Uganda: A modelling study. Sex Transm Infect 87: A37. doi:10.1136/sextrans-2011-050109.36.
35. Wilson DP, Fairley CK, Sankar D, Williams H, Keen P, et al. (2011) Replacement of conventional HIV testing with rapid testing: mathematical modelling to predict the impact on further HIV transmission between men. Sex Transm Infect 87: 588-593. doi:10.1136/sextrans-2011-050002. PubMed: 21934115.
36. Hoare A, Gray RT, Wilson DP, (2012) Could implementation of Australia's National Gay Men's Syphilis Action Plan have an indirect effect on the HIV epidemic? Sex Health 9: 144-151. PubMed: 22498158.
37. Bendavid E, Brandeau ML, Wood R, Owens DK, (2010) Comparative Effectiveness of HIV Testing and Treatment in Highly Endemic Regions. Arch Intern Med 170: 1347-1354. doi:10.1001/archinternmed.2010.249. PubMed: 20696960.
38. Hontelez JAC, De Vlas SJ, Baltussen R, Newell ML, Bakker R, et al. (2012) The impact of antiretroviral treatment on the age composition of the HIV epidemic in sub-Saharan Africa. AIDS 26: S19-S30. doi:10.1097/QAD.0b013e3283558526. PubMed: 22781175.
39. Hallett TB, Baeten JM, Heffron R, Barnabas R, de Bruyn G, et al. (2011) Optimal uses of antiretrovirals for prevention in HIV-1 serodiscordant heterosexual couples in South Africa: a modelling study. PLOS Med 8: e1001123. PubMed: 22110407.
40. Freeman EE, White RG, Bakker R, Orroth KK, Weiss HA, et al. (2009) Population-level effect of potential HSV2 prophylactic vaccines on HIV incidence in sub-Saharan Africa. Vaccine 27: 940-946. doi:10.1016/j.vaccine.2008.11.074. PubMed: 19071187.
41. Korenromp EL, Van Vliet C, Grosskurth H, Gavyole A, Van der Ploeg CP, et al. (2000) Model-based evaluation of single-round mass treatment of sexually transmitted diseases for HIV control in a rural African population. AIDS 14: 573-593. doi:10.1097/00002030-200003310-00013. PubMed: 10780720.
42. Korenromp EL, Bakker R, de Vlas SJ, Gray RH, Wawer MJ, et al. (2002) HIV dynamics and behaviour change as determinants of the impact of sexually transmitted disease treatment on HIV transmission in the context of the Rakai trial. AIDS 16: 2209-2218. doi:10.1097/00002030-200211080-00014. PubMed: 12409743.
43. Korenromp EL, White RG, Orroth KK, Bakker R, Kamali A, et al. (2005) Determinants of the impact of sexually transmitted infection treatment on prevention of HIV infection: A synthesis of evidence from the Mwanza, Rakai, and Masaka intervention trials. J Infect Dis 191: S168-S178. doi:10.1086/425274. PubMed: 15627227.
44. White RG, Orroth KK, Korenromp EL, Bakker R, Wambura M, et al. (2004) Can population differences explain the contrasting results of the Mwanza, Rakai, and Masaka HIV/sexually transmitted disease intervention trials?: A modeling study. J Acquir Immune Defic Syndr 37: 1500-1513. doi:10.1097/01.qai.0000127062.94627.31. PubMed: 15602129.
45. Korenromp EL, Bakker R, Gray R, Wawer MJ, Serwadda D, et al. (2002) The effect of HIV, behavioural change, and STD syndromic management on STD epidemiology in sub-Saharan Africa: Simulations of Uganda. Sex Transm Infect 78: i55-i63. doi:10.1136/sti.78.suppl_1.i55. PubMed: 12083448.
46. McCabe CJ, Goldie SJ, Fisman DN, (2010) The Cost-Effectiveness of Directly Observed Highly-Active Antiretroviral Therapy in the Third Trimester in HIV-Infected Pregnant Women. PLOS ONE 5: e10154. PubMed: 20405011.
47. Rauner MS, Brailsford SC, Flessa S, (2005) Use of discrete-event simulation to evaluate strategies for the prevention of mother-to-child transmission of HIV in developing countries. J Oper Res Soc 56: 222-233. doi:10.1057/palgrave.jors.2601884.
48. Atkinson J, (1996) A simulation model of the dynamics of HIV transmission in intravenous drug users. Comput Biomed Res 29: 338-349. doi:10.1006/cbmr.1996.0025. PubMed: 8812079.
49. Grimm V, Railsback SF, (2005) Individual-based modeling and ecology. Princeton University Press.
50. Athanasiadis IN, Mitkas PA, (2004) An agent-based intelligent environmental monitoring system. Manag Environ Qual 15: 238-249. doi:10.1108/14777830410531216.
51. Chu L, Liu HX, Oh J-S, Recker W, (2003) A calibration procedure for microscopic traffic simulation. IEEE: pp. 1574-1579.
52. Epstein JM, (2009) Modelling to contain pandemics. Nature 460: 687-687. doi:10.1038/460687a. PubMed: 19661897.